U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT06917950) titled 'Roxadustat for Bone and Neuropsychiatric Aspects in Hemodialysis Patients' on March 27.
Brief Summary: People with severe kidney failure who need regular hemodialysis treatment often experience several health problems. These include anemia (low red blood cell count), issues with their bone health (sometimes called mineral and bone disease), and mental health challenges like depression and anxiety. They may also have problems with their nerves and muscles.
Roxadustat is a newer medicine, taken as a pill, used to treat anemia caused by kidney disease. It works differently than the standard injectable medications often used.
This st...